These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 1980342)
1. Distribution and rearrangements of alleles of c-Ha-ras-1 protooncogene and their correlation with the development of lung, ovarian and thyroid cancers. Knyazev PG; Nikiforova IF; Serova OM; Pluzhnikova GF Neoplasma; 1990; 37(6):647-55. PubMed ID: 1980342 [TBL] [Abstract][Full Text] [Related]
2. [Frequency and rearrangements of alleles of proto-oncogene c-Ha-ras-1 and their association with development of various malignant tumors in man]. Nikiforova IF; Serova OM; Pluzhnikova GF; Kniazev PG; Seĭts IF Genetika; 1990 Mar; 26(3):531-40. PubMed ID: 1972367 [TBL] [Abstract][Full Text] [Related]
3. [Alterations of c-myc and c-Ha-ras-1 oncogenes in human ovarian cancer]. Serova OM; Nikiforova IF; Iurkova LE; Vinokurov VL; Kniazev PG Eksp Onkol; 1990; 12(6):47-9. PubMed ID: 2261877 [TBL] [Abstract][Full Text] [Related]
4. [Restriction polymorphism of the proto-oncogene c-Ha-ras-1 in patients with multiple primary malignant neoplasms and non-small-cell lung cancer]. Gaspar'ian AV; Sel'chuk VIu; Iakubovskaia MG; Zborovskaia IB; Tatosian AG Genetika; 1997 Jan; 33(1):96-100. PubMed ID: 9162692 [TBL] [Abstract][Full Text] [Related]
5. c-Ha-ras polymorphism in patients with hepatocellular carcinoma. Comparison of healthy subjects and alcoholic patients with cirrhosis. Thelu MA; Zarski JP; Froissart B; Rachail M; Seigneurin JM Gastroenterol Clin Biol; 1993; 17(12):903-7. PubMed ID: 7907302 [TBL] [Abstract][Full Text] [Related]
6. Hypomethylation of CCGG sites in the 3' region of H-ras protooncogene is frequent and is associated with H-ras allele loss in non-small cell lung cancer. Vachtenheim J; Horáková I; Novotná H Cancer Res; 1994 Mar; 54(5):1145-8. PubMed ID: 8118795 [TBL] [Abstract][Full Text] [Related]
7. [The role of the constitutional features and rearrangement of the H-ras 1 oncogene in the development of human lung cancer]. Nikiforova IF; Maksimishina MG; Lemekhov VG; Kniazev PG Vopr Med Khim; 1991; 37(6):64-8. PubMed ID: 1687495 [TBL] [Abstract][Full Text] [Related]
8. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas. Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420 [TBL] [Abstract][Full Text] [Related]
9. Allele loss from chromosome 17 in ovarian cancer. Russell SE; Hickey GI; Lowry WS; White P; Atkinson RJ Oncogene; 1990 Oct; 5(10):1581-3. PubMed ID: 2250914 [TBL] [Abstract][Full Text] [Related]
10. [Loss of Ha-ras alleles in DNA from gastric carcinoma tissue of Chinese individuals]. Shan X Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Jun; 13(3):171-5. PubMed ID: 1678994 [TBL] [Abstract][Full Text] [Related]
11. Association of rare alleles of the Harvey ras protooncogene locus with lung cancer. Sugimura H; Caporaso NE; Modali RV; Hoover RN; Resau JH; Trump BF; Longergan JA; Krontiris TG; Mann DL; Weston A Cancer Res; 1990 Mar; 50(6):1857-62. PubMed ID: 2407346 [TBL] [Abstract][Full Text] [Related]
12. Ha-ras oncogene (codon 12) mutation in thyroid carcinogenesis: analysis of 60 benign and malignant thyroid tumors. Bouras M; Parvaz P; Berger N; Paulin C; Revol A Ann Biol Clin (Paris); 1995; 53(10-11):549-55. PubMed ID: 8787281 [TBL] [Abstract][Full Text] [Related]
13. c-Ha-ras-1 polymorphism in human breast carcinomas: evidence for a normal distribution of alleles. Sheng ZM; Guerin M; Gabillot M; Spielmann M; Riou G Oncogene Res; 1988 Feb; 2(3):245-50. PubMed ID: 2897104 [TBL] [Abstract][Full Text] [Related]
14. c-Ha-ras BamHI RFLP in human urothelial tumors and point mutations in hot codons. Weismanová E; Kalúz S; Skorvaga M Neoplasma; 1993; 40(4):223-7. PubMed ID: 7903794 [TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of the genes encoding urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in advanced ovarian cancer. Türkmen B; Schmitt M; Schmalfeldt B; Trommler P; Hell W; Creutzburg S; Graeff H; Magdolen V Electrophoresis; 1997 May; 18(5):686-9. PubMed ID: 9194591 [TBL] [Abstract][Full Text] [Related]
16. Genetic susceptibility associated with rare HRAS1 variable number of tandem repeats alleles in Spanish non-small cell lung cancer patients. Rosell R; Calvo R; Sánchez JJ; Maurel J; Guillot M; Monzó M; Núñez L; Barnadas A Clin Cancer Res; 1999 Jul; 5(7):1849-54. PubMed ID: 10430091 [TBL] [Abstract][Full Text] [Related]
17. Allele loss at the c-Ha-ras1 locus in human ovarian cancer. Lee JH; Kavanagh JJ; Wharton JT; Wildrick DM; Blick M Cancer Res; 1989 Mar; 49(5):1220-2. PubMed ID: 2917352 [TBL] [Abstract][Full Text] [Related]
18. Restriction fragment length polymorphism and activation of c-Ha-ras gene in urothelial cancer. Ishikawa J; Maeda S; Kamidono S; Sugiyama T Anticancer Res; 1988; 8(5A):915-24. PubMed ID: 2902823 [TBL] [Abstract][Full Text] [Related]
19. A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locus. Jacobs IJ; Smith SA; Wiseman RW; Futreal PA; Harrington T; Osborne RJ; Leech V; Molyneux A; Berchuck A; Ponder BA Cancer Res; 1993 Mar; 53(6):1218-21. PubMed ID: 8095178 [TBL] [Abstract][Full Text] [Related]